Therapeutics Initiative |

27 Jan Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia

Posted at 15:56h in PharmacoEpidemiology 0 Comments

Fisher, A., Kim, J.D., Carney, G. et al. Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia. BMC Rheumatol 6, 5 (2022)...

07 Sep Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study

Posted at 13:00h in PharmacoEpidemiology 0 Comments

Colin R. Dormuth, Anat Fisher, Marie Hudson, Peter C. Austin, Pierre Ernst, Lauren Bresee, Dan Chateau, Hala Tamim, J. Michael Paterson, Jean Philippe Lafrance, Regina M. Taylor-Gjevre, Robert W. Platt, Canadian Network for Observational Drug...

Drug switching Tag

27 Jan Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia

07 Sep Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study

Contact

Subscribe for Updates